LYC-30937-EC

· Lycera Corp.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LYC-30937-EC, covering 2019-03-27 to 2019-04-02. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type Psoriasis [Phase 2]